Skip to main content
. 2019 Sep 26;70(10):2036–2044. doi: 10.1093/cid/ciz578

Table 3.

Serogroup-specific Case Fatality Rate by Case Characteristics, Clinical Manifestation, and Symptoms at Disease Onset Among Invasive Meningococcal Disease Cases, the Netherlands, January 2015 to June 2018

W B Y C Total
CFR n CFR n CFR n CFR n CFR n P Valuea
Age .216
 <10 y 11.1 2/18 3.8 4/104 0.0 0/1 0.0 0/3 4.8 6/126
 10–19 y 24.1 7/29 3.8 2/52 28.6 2/7 0.0 0/2 12.2 11/90
 20–64 y 17.3 14/81 4.2 3/72 7.7 1/13 0.0 0/10 10.2 18/176
 ≥65 y 13.8 9/65 2.9 1/34 2.7 1/37 90.0 1/10 8.2 12/146
Genderb .964
 Males 16.4 11/67 5.0 6/121 11.5 3/26 0.0 0/12 8.8 20/226
 Females 16.5 21/127 2.8 4/142 3.1 1/32 7.7 1/12 8.6 27/314
Comorbidities .163
 No 18.0 22/122 3.7 6/163 6.5 2/31 0.0 0/16 9.0 30/332
 Yes, immunocompromised 21.1 4/19 33.3 3/9 0.0 0/8 0.0 0/1 19.4 7/36
 Yes, other 13.0 3/23 0.0 0/17 12.5 1/8 0.0 0/2 8.0 4/50
Clinical manifestations <.001
 Septicemia without meningitis 27.1 23/85 9.5 6/63 10.5 2/19 14.3 1/7 18.4 32/174
 Septicemia and meningitis 36.4 4/11 8.0 2/25 28.6 2/7 0.0 0/1 18.2 8/44
 Meningitis without septicemia 3.1 1/32 1.4 2/142 0.0 0/12 0.0 0/8 1.5 3/194
 Other 6.2 4/65 0.0 0/30 0.0 0/19 0.0 0/9 3.3 4/123
Symptomsc: diarrhea <.001
 No 10.6 12/113 6.2 7/112 3.2 1/31 0.0 0/10 7.5 20/266
 Yes, with IMD-specific symptomsd 40.0 2/5 0.0 0/5 NaN 0/0 0.0 0/1 18.2 2/11
 Yes, without IMD-specific symptomsd 52.4 11/21 0.0 0/6 0.0 0/4 0.0 0/1 34.4 11/32

Data are from January to June. Two cases of IMD-E (1 case) and IMD-X (1 case) are not included in the table. Total includes cases of serogroup W, B, Y, and C.

Abbreviations: CFR, case fatality rate; IMD, invasive meningococcal disease; NaN, not a number (dividing by zero is undefined).

a P values for the difference between variables and CFR among cases from all serogroups.

bOne case with missing information on gender.

cData available only since 2017.

dIMD-specific symptoms: petechiae and/or neck stiffness.